| Q40434847 | A case of necrotizing fasciitis with septic shock in a cat caused by Acinetobacter baumannii |
| Q34493690 | A confirmed case of toxic shock syndrome associated with the use of a menstrual cup |
| Q35063827 | A model of an integrated immune system pathway in Homo sapiens and its interaction with superantigen producing expression regulatory pathway in Staphylococcus aureus: comparing behavior of pathogen perturbed and unperturbed pathway |
| Q73197852 | A model of human whole blood lymphokine release for in vitro and ex vivo use |
| Q36846277 | A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes |
| Q44889548 | A quantitative real-time immuno-PCR approach for detection of staphylococcal enterotoxins |
| Q35755287 | Antigen specificity and T-cell clonality in periodontal disease |
| Q39816086 | Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin. |
| Q40120789 | Bacterial deception of MAIT cells in a cloud of superantigen and cytokines |
| Q37255066 | Biofilms and chronic wound inflammation. |
| Q42737364 | Biotyping of enterotoxigenic Staphylococcus aureus by enterotoxin gene cluster (egc) polymorphism and spa typing analyses |
| Q34146648 | Both positive and negative effects on immune responses by expression of a second class II MHC molecule. |
| Q38300843 | Bromine, bear-claw scratch fasciotomies, and the Eagle effect: management of group A streptococcal necrotising fasciitis and its association with trauma |
| Q58442172 | Comparative Prevalence of Superantigen Genes in Staphylococcus aureus Isolates Causing Sepsis With and Without Septic Shock |
| Q33720576 | Construction of a single-chain variable-fragment antibody against the superantigen Staphylococcal enterotoxin B |
| Q39896685 | Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity. |
| Q28606800 | Convergent capture of retroviral superantigens by mammalian herpesviruses |
| Q30887267 | Detection of secreted peptides by using hypothesis-driven multistage mass spectrometry |
| Q81453339 | Detection of the enterotoxins A, B, and C genes in Staphylococcus aureus from goat and bovine mastitis in Brazilian dairy herds |
| Q38089734 | Diagnosis and treatment of invasive group A streptococcal infections |
| Q42549284 | Differential geometric analysis of alterations in MH α-helices |
| Q36925995 | Distribution of tsst-1 and mecA Genes in Staphylococcus aureus Isolated From Clinical Specimens |
| Q41833050 | Diverse enterotoxin gene profiles among clonal complexes of Staphylococcus aureus isolates from the Bronx, New York |
| Q56454076 | Doença de Kawasaki |
| Q48128042 | Effects of bacterial superantigens on behavior of mice in the elevated plus maze and light-dark box. |
| Q51894958 | Electrical activity in rat cortico-limbic structures after single or repeated administration of lipopolysaccharide or staphylococcal enterotoxin B. |
| Q37658207 | Emergence of a novel lineage containing a prophage in emm/M3 group A Streptococcus associated with upsurge in invasive disease in the UK. |
| Q37827062 | Endodontic microbiology |
| Q39749470 | Epidemiology and virulence insights from MRSA and MSSA genome analysis |
| Q91935600 | Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions |
| Q45434695 | Fascinating interaction between host and pathogen |
| Q37459829 | Gram-positive toxic shock syndromes |
| Q28249822 | HLA-DQ6 and ingestion of contaminated water: possible gene-environment interaction in an outbreak of Leptospirosis |
| Q36497719 | Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease |
| Q37104744 | Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression |
| Q34290744 | Identification of three novel superantigen-encoding genes in Streptococcus equi subsp. zooepidemicus, szeF, szeN, and szeP. |
| Q33991798 | Immune evasion by staphylococci |
| Q36409380 | Immunomodulation and Disease Tolerance to Staphylococcus aureus |
| Q39825776 | Impaired interleukin-8 chemokine secretion by staphylococcus aureus-activated epithelium and T-cell chemotaxis in cystic fibrosis. |
| Q38003716 | Infectious complications of dermatologic procedures |
| Q36797409 | Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps |
| Q49980459 | Innate immune responses following Kawasaki disease and toxic shock syndrome. |
| Q40759964 | Intrauterine device infection causing concomitant streptococcal toxic shock syndrome and pelvic abscess with Actinomyces odontolyticus bacteraemia |
| Q38017734 | Invasive group a streptococcal disease: epidemiology, pathogenesis and management. |
| Q28176655 | Kawasaki disease: what is the epidemiology telling us about the etiology? |
| Q37501623 | Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome |
| Q58775766 | Messing with the Sentinels-The Interaction of with Dendritic Cells |
| Q35585080 | Microbial Superantigens as Virulence Factors and Ways to Counteract Their Actions |
| Q34056748 | Molecular pathogenesis of Staphylococcus aureus infection |
| Q24630727 | NVC-422 inactivates Staphylococcus aureus toxins |
| Q90656937 | Pathogen infection and autoimmune disease |
| Q59354446 | Pathogens and autoimmune hepatitis |
| Q35735971 | Pathophysiologic mechanisms of chronic rhinosinusitis |
| Q43013547 | Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators |
| Q47733082 | Prevalence of Staphylococcus aureus strains in an Australian cohort, 1989-2003: evidence for the low prevalence of the toxic shock toxin and Panton-Valentine leukocidin genes. |
| Q34943643 | Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315. |
| Q43230486 | Protective effect of glutathione S-transferase-fused mutant staphylococcal enterotoxin C against Staphylococcus aureus-induced bovine mastitis |
| Q36513761 | Recurrent infections and immune evasion strategies of Staphylococcus aureus. |
| Q42637980 | Report of a strain of Staphylococcus caprae with the genes for enterotoxin A and enterotoxin-like toxin type P. |
| Q36980187 | Review: variability of host-pathogen interaction |
| Q54375209 | Role of Kupffer cells in pathogenesis of sepsis-induced drug metabolizing dysfunction. |
| Q43497971 | Serum capacity to neutralize superantigens does not affect the outcome of Staphylococcus aureus bacteremia |
| Q40050422 | Shocking superantigens promote establishment of bacterial infection |
| Q40075380 | Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation |
| Q52007025 | Staphylococcal enterotoxin B induces anergy to conventional peptide in memory T cells. |
| Q26995577 | Staphylococcal superantigens in colonization and disease |
| Q35062065 | Staphylococcal toxic shock syndrome caused by tampon use. |
| Q37838814 | Staphylococcal toxic shock syndrome: mechanisms and management |
| Q39094247 | Staphylococcus aureus clinical isolates: antibiotic susceptibility, molecular characteristics, and ability to form biofilm |
| Q39978166 | Staphylococcus aureus enterotoxin C2 mutants: biological activity assay in vitro |
| Q54613415 | Staphylococcus aureus isolates from Irish domestic refrigerators possess novel enterotoxin and enterotoxin-like genes and are clonal in nature. |
| Q52887262 | Staphylococcus aureus, Toll-like receptors, superantigens, and their derivatives. |
| Q38103994 | Strangles: taking steps towards eradication |
| Q21563432 | Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. |
| Q58734570 | Streptococcal toxic shock syndrome in the intensive care unit |
| Q37726602 | Streptococcus agalactiae toxic shock-like syndrome: two case reports and review of the literature |
| Q51184519 | Streptococcus dysgalactiae cellulitis and toxic shock like syndrome in a Brown Swiss cow. |
| Q46450201 | Suitability of a recombinant Staphylococcus aureus enterotoxin C bovine variant for immunodiagnostics and therapeutic vaccine development |
| Q50527665 | Superantigen staphylococcal enterotoxin C1 inhibits the growth of bladder cancer. |
| Q35439554 | Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells |
| Q34437647 | Superantigenic activity of emm3 Streptococcus pyogenes is abrogated by a conserved, naturally occurring smeZ mutation |
| Q35662947 | Superantigens Modulate Bacterial Density during Staphylococcus aureus Nasal Colonization |
| Q42942766 | Superantigens and chronic rhinosinusitis: skewing of T-cell receptor V beta-distributions in polyp-derived CD4+ and CD8+ T cells |
| Q35108860 | Superantigens in Staphylococcus aureus isolated from prosthetic joint infection. |
| Q34298337 | Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo |
| Q47691893 | T cell chemotaxis and chemokine release after Staphylococcus aureus interaction with polarized airway epithelium |
| Q92853675 | The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections |
| Q50761738 | The Treatment of Severe Group A Streptococcal Infections. |
| Q36038834 | The dynamics of T cells during persistent Staphylococcus aureus infection: from antigen-reactivity to in vivo anergy |
| Q34990709 | The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence |
| Q43765653 | The nature of innate and adaptive interleukin-17A responses in sham or bacterial inoculation |
| Q47733868 | Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. |
| Q38818505 | Toxic shock syndrome in Australian children. |
| Q34556079 | Toxic shock syndrome in children: epidemiology, pathogenesis, and management |
| Q42216913 | Toxic shock syndrome surveillance in UK children |
| Q36018208 | Two common structural motifs for TCR recognition by staphylococcal enterotoxins |
| Q38021366 | Vaccination against rheumatic heart disease: a review of current research strategies and challenges |
| Q79285415 | Which therapeutic prospects in the septic syndrome? |